Vir Biotechnology Inc (VIR) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 100.08%-0.19 | 238.95 | -0.03 | 64.07 | 0.24 |
19.10%24.43 | 30.20 | 23.34 | - | - | |
| Selling, General, and Administrative | 19.10%24.43 | 30.20 | 23.34 | - | - |
| Research and Development | 40.84%80.04 | 135.28 | 108.92 | - | - |
| Costs And Expenses | 36.87%104.47 | 165.48 | 132.26 | 111.99 | 173.68 |
| Operating Income/Loss | 242.46%-104.66 | 73.47 | -132.29 | -47.92 | -173.44 |
| Nonoperating Income/Loss | 21.66%8.26 | 6.79 | 6.77 | 4.86 | 10.47 |
| Income/Loss From Continuing Operations Before Tax | 220.10%-96.40 | 80.26 | -125.53 | -43.06 | -162.97 |
| Income Tax Expense/Benefit | 179.89%-0.14 | 0.18 | 0.17 | -0.14 | 0.17 |
220.19%-96.25 | 80.08 | -125.70 | -42.92 | -163.14 | |
| Attributable To Parent | 220.19%-96.25 | 80.08 | -125.70 | -42.92 | -163.14 |
| Basic Average Shares | 0.93%169.28 | 167.72 | 147.36 | 0.23 | 138.93 |
| Diluted Average Shares | 0.23%169.28 | 168.88 | 147.36 | 0.23 | 138.93 |
| Basic Earnings Per Share | 218.75%-0.57 | 0.48 | -0.85 | -0.30 | -1.17 |
| Diluted Earnings Per Share | 221.28%-0.57 | 0.47 | -0.85 | -0.30 | -1.17 |